Skip to main content
# Title Research Year
201 CD30 Expression vs. Serum Soluble CD30 (sCD30) Level: Role in Prognosis and Treatment of Acute Myeloid Leukaemia 2017
202 Characterization of the Pathogenicity of Novel Sequence Variants Identified in Type 1 VWD Subjects in the Zimmerman Program for the Molecular and Clinical Biology Study 2017
203 Serum IL-17 in patients with erythema multiforme or Stevens– Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity 2017
204 Toll Like receptor 3 polymorphisms in hepatitis B virus infection 2017
205 CD30 expression versus serum soluble CD30 level as a prognostic markers in acute lymphoblastic leukemia 2017
206 Correlation of anti-cardiolipin antibodies with right ventricular systolic
strain in systemic lupus erythematosus patients
2017
207 Effect of cold storage on platelets quality stored in a small containers:
Implications for pediatric transfusion
2017
208 CD30 expression versus serum soluble CD30 level as a prognostic markers in acute lymphoblastic leukemia 2017
209 Methylated SFRP1,2 and CD25 Expression in Acute Myeloid Leukemia Play an Important Role in the Pathogenesis of the Disease and in Turn in its Treatment 2016
210 Clonality Assessment of B Non-Hodgkin's Lymphoma by Multiparameter Flow Cytometry of Bone Marrow Biopsy: an Additional Diagnostic Tool 2016